Recurrence Rates of Aggressive Histologic Types of Basal Cell Carcinoma After Treatment with Electrodesiccation and Curettage Alone

Blixt, Elizabeth K.; Nelsen, David D.; Stratman, Erik J.

doi:10.1111/dsu.12122

Cited by 49 publications

(33 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Dear Editor , An easy, cheap and practical therapy for nodular basal cell carcinoma (nBCC) is curettage combined with electrodessication (C&ED) . Recurrence rates for BCC after C&ED range from 1% to 27%, influenced by anatomical location, histopathological growth pattern and size . Therefore, most guidelines recommend C&ED as treatment solely in low‐risk BCC, typically defined as primary and small BCC (≤ 5 mm) with no clinical suspicion of infiltrative growth in low‐risk areas [outside the H‐zone (nasolabial fold, nasal alae, orbital area and auricular area)].…”

Section: Patient and Tumour Characteristics In A Retrospective Study supporting

confidence: 80%

“…Although an infiltrative growth pattern was not found to be a risk factor for recurrence in this study, the number of tumours containing a (partial) infiltrative growth pattern was relatively low and future research is needed to draw further conclusions. The recurrence rate in this study (6%) falls within the range of recurrence rates presented in earlier studies (1–27%) . Our follow‐up time was relatively short considering recurrences could appear many years after initial treatment, and a longer follow‐up time is suggested for future research.…”

Section: Patient and Tumour Characteristics In A Retrospective Study contrasting

confidence: 59%

See 1 more Smart Citation

A retrospective study on the effectiveness of curettage and electrodesiccation for clinically suspected primary nodular basal cell carcinoma

Lubeek

Arnold

2016

Br J Dermatol

View full text Add to dashboard Cite

A retrospective study on the effectiveness of curettage and electrodesiccation for clinically suspected primary nodular basal cell carcinoma An easy, cheap, and practical therapy for nodular basal cell carcinoma (nBCC) is curettage combined with electrodessication (C&ED). 1,2 Recurrence rates for BCC after C&ED range from 1-27%, influenced by anatomic location, histopathologic growth pattern, and size. 2-7

show abstract

Section: Patient and Tumour Characteristics In A Retrospective Study supporting

confidence: 80%

Section: Patient and Tumour Characteristics In A Retrospective Study contrasting

confidence: 59%

A retrospective study on the effectiveness of curettage and electrodesiccation for clinically suspected primary nodular basal cell carcinoma

Lubeek

Arnold

2016

Br J Dermatol

View full text Add to dashboard Cite

show abstract

“…Previous literature on BCC in high-risk areas, including facial areas, recommend that ED&C should not be the primary treatment for tumors, and surgical excision is advised [7] . Due to our wide inclusion criteria, tumors that would not have been traditionally treated with ED&C (including lesions greater than 2 cm in size), lesions with aggressive histological subtype including micronodular and morpheaform BCC [12] , and lesions in high-risk locations including the Hzone [13] were included in the study, lowering our overall success rates.…”

Section: Discussionmentioning

confidence: 99%

Early Detection of Desiccation and Curettage Failure in the Treatment of Basal Cell Carcinoma

Woldow

Melvin²

2016

Dermatology

View full text Add to dashboard Cite

Background/Aims: Basal cell carcinoma (BCC) is a malignant neoplasm of keratinocytes. Electrodessication and curettage (ED&C) published cure rates vary widely, and the authors of this study are unaware of any previous literature which has attempted to rapidly identify treatment failures. Objective: To identify BCC ED&C failures by histologically analyzing the fragments produced by the third round of curettage. Methods: The monitoring of routine therapy of 862 cases of BCC that were treated by ED&C followed by the submission of cautery fragments of the third round of curettage for histological and immunohistochemical testing. Results: Of the 862 cases, 764 (89%) had no residual BCC seen in their curetting. Of these patients, zero recurrences (0%) were noted. Forty-eight of the 862 cases had residual BCC seen in their curetting and elected to receive no additional therapy. Eighteen (38%) had a recurrence detected. Fifty of the 862 cases had residual BCC seen in their curetting and elected for immediate re-excision. Thirty-five (70%) had histological evidence of residual BCC. Limitations: The study was performed at a single center with 2 years of follow-up. Conclusion: Pathological examination of curettage fragments in combination with immunohistochemistry testing appears to be beneficial in predicting which patients are likely to have recurrence of BCC after ED&C.

show abstract

“…Düşük riskli BHK ve SHK için bildirilen 5 yıllık kür oranları sırasıyla %92 ve %96'dır (5,6). Ancak yerleşim ve histopatolojik alt tip açısından yüksek risk taşıyanlarda rekürrens oranları sırasıyla %21 ve %27'ye kadar yükselmektedir (7,8).…”

Section: Küretaj Ve Elektrodesikasyonunclassified

Surgical Treatment of Skin Tumors

Elçin¹

2015

tdd

View full text Add to dashboard Cite

İster iyi huylu, ister kötü huylu olsun deride yerleşen herhangi bir tümörünün cerrahi tedavisi denildiğinde akla ilk gelen yöntem eksizyondur. Eliptik eksizyon dermatolojik cerrahinin temel yapı taşıdır. Her eksizyondan geriye fonksiyonel ve kozmetik olarak onarmakla yükümlü olduğumuz bir deri defekti kalır. Defektin boyutunu eksize ettiğimiz tümörün boyutu ve kullandığımız güvenlik sınırı belirler. Yan ve derin cerrahi sınırlar uygun cerrahi yöntemle tümörsüz hale getirildikten sonra oluşan defektin boyutu ve yerleşimi gözetilerek sekonder yara iyileşmesi, primer onarım, flepler veya tam veya kısmi kalınlıkta greft yöntemlerinden o defekt için en iyi kozmetik ve fonksiyonel sonucu verecek olanla onarım yapılır. Bu derlemede deri tümörleri için sık kullanılan dermatolojik cerrahi yöntemlerin yanı sıra, ülkemizde henüz rutin olarak kullanılmayan ancak yüksek riskli bazal hücreli karsinom (BHK) ve skuamöz hücreli karsinomun (SHK) cerrahi tedavisinde ilk seçenek olarak önerilen Mohs cerrahisi de anlatılacaktır. Gonca Elçin Deri Tümörlerinin Cerrahi Tedavisi Surgical Treatment of Skin Tumors Özet AbstractWhen we mention about surgical treatment of any tumor residing on the skin independent of its benign or malignant nature, the first method we recall is excision. Elliptical excision is the mainstay of the dermatologic surgery. Each excision ends with a defect for which we are responsible to repair functionally and cosmetically. The diameter of the tumor we excised and the safety margin used for excision determine the diameter of the final defect. After achieving tumor free lateral and deep margins with the appropriate surgical method, we decide between the repair options of second intention healing, primary repair, flaps, full or split thickness grafts, considering the diameter and the anatomic localization of the defect, for the best functional and cosmetic result for that specific defect. This review overviews not only the most common dermatologic surgical methods, but also Mohs surgery which is a method rarely used in our country, although it is the treatment of choice for the treatment of high risk basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).

show abstract

Recurrence Rates of Aggressive Histologic Types of Basal Cell Carcinoma After Treatment with Electrodesiccation and Curettage Alone

Abstract: We report a 27% recurrence rate for histologically aggressive BCCs treated using EDC alone with median 6.5 years follow-up.

Cited by 49 publications

References 30 publications

A retrospective study on the effectiveness of curettage and electrodesiccation for clinically suspected primary nodular basal cell carcinoma

A retrospective study on the effectiveness of curettage and electrodesiccation for clinically suspected primary nodular basal cell carcinoma

Early Detection of Desiccation and Curettage Failure in the Treatment of Basal Cell Carcinoma

Surgical Treatment of Skin Tumors

Contact Info

Product

Resources

About